Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CHIMERIX INC | 1,543,394 | reported | 18 Mar 2014 | tx 1−700,000 |
| ARRAY BIOPHARMA INC | 25,000 | reported | 23 Oct 2013 | tx 10+45,000−3,376,186 |
| Upstream Bio, Inc. | 17,096 | reported | 10 Jun 2025 | tx 2+34,192 |
| Passage BIO, Inc. | 16,918 | reported | 27 May 2021 | tx 7+2,672,984−2,066,630 |
| Deciphera Pharmaceuticals, Inc. | 12,000 | reported | 17 May 2018 | tx 12+4,116,140−660,025 |
| ARVINAS, INC. | 10,192 | reported | 16 Jun 2022 | tx 57+3,173,454−4,856,926 |
| Climb Bio, Inc. | 10,000 | reported | 26 Jun 2024 | tx 4+50,000 |
| Disc Medicine, Inc. | 10,000 | reported | 11 Jun 2025 | tx 4+34,136 |
| PDS Biotechnology Corp | 10,000 | reported | 15 Mar 2019 | tx 6+85,000−10,000 |
| Cogent Biosciences, Inc. | 7,881 | reported | 14 Jun 2019 | tx 11+1,816,730−1,955,671 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 Jun 2025 | GRANT_AWARD | Disc Medicine, Inc. | 10,000 | 0.00 USD | deriv |
| 10 Jun 2025 | GRANT_AWARD | Upstream Bio, Inc. | 17,096 | 0.00 USD | deriv |
| 10 Oct 2024 | GRANT_AWARD | Upstream Bio, Inc. | 17,096 | 0.00 USD | deriv |
| 26 Jun 2024 | GRANT_AWARD | Climb Bio, Inc. | 10,000 | 0.00 USD | deriv |
| 12 Jun 2024 | GRANT_AWARD | Disc Medicine, Inc. | 10,000 | 0.00 USD | deriv |
| 09 Jun 2023 | GRANT_AWARD | Disc Medicine, Inc. | 7,136 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | Climb Bio, Inc. | 10,000 | 0.00 USD | deriv |
| 29 Dec 2022 | GRANT_AWARD | Disc Medicine, Inc. | 7,000 | 0.00 USD | deriv |
| 16 Jun 2022 | GRANT_AWARD | ARVINAS, INC. | 10,192 | 0.00 USD | deriv |
| 19 May 2022 | GRANT_AWARD | Climb Bio, Inc. | 10,000 | 0.00 USD | deriv |
| 15 Dec 2021 | SALE | ARVINAS, INC. | 5,695 | 65.74 USD | |
| 16 Dec 2021 | SALE | ARVINAS, INC. | 48,499 | 69.66 USD | |
| 16 Dec 2021 | SALE | ARVINAS, INC. | 37,206 | 68.97 USD | |
| 14 Dec 2021 | SALE | ARVINAS, INC. | 119,456 | 66.01 USD | |
| 14 Dec 2021 | SALE | ARVINAS, INC. | 36,308 | 65.38 USD | |
| 14 Dec 2021 | SALE | ARVINAS, INC. | 700 | 64.20 USD | |
| 15 Dec 2021 | SALE | ARVINAS, INC. | 40,292 | 67.46 USD | |
| 15 Dec 2021 | SALE | ARVINAS, INC. | 67,549 | 66.50 USD | |
| 12 Nov 2021 | SALE | ARVINAS, INC. | 17,449 | 85.96 USD | |
| 12 Nov 2021 | SALE | ARVINAS, INC. | 9,660 | 84.31 USD | |
| 12 Nov 2021 | SALE | ARVINAS, INC. | 12,760 | 84.02 USD | |
| 15 Nov 2021 | SALE | ARVINAS, INC. | 17,752 | 85.07 USD | |
| 15 Nov 2021 | SALE | ARVINAS, INC. | 3,532 | 83.90 USD | |
| 10 Nov 2021 | SALE | ARVINAS, INC. | 1,852 | 90.18 USD | |
| 11 Nov 2021 | SALE | ARVINAS, INC. | 36,210 | 85.92 USD |
1 purchase reported after at least 12 months of silence — most recent on 12 Nov 2019.